Compare Charles River Laboratories Intl. Inc (CRL) vs iShares Bitcoin Trust (IBIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares Bitcoin Trust — how do they compare? Charles River Laboratories Intl. Inc trades at $302.17 (market cap $14.23B), while iShares Bitcoin Trust trades at $46.87 (market cap $67.31B). The key difference: iShares Bitcoin Trust is far larger — about 4.7× Charles River Laboratories Intl. Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and iShares Bitcoin Trust for 40 Days on average.
| CRL | IBIT | |
|---|---|---|
Market Cap | $14.23B | $67.31B |
Volume | 1,176,885 | 56,154,544 |
Sector | Health | Crypto-linked |
52-Week High | $310.77 | $68.74 |
52-Week Low | $149.93 | $33.29 |
Typical Hold Time | 33 Days | 40 Days |
Enterprise Value | $17.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
IBIT trades at $46.76, down 0.95% on the day, with technical indicators showing mixed signals. The overall technical outlook is bearish despite moving averages suggesting some bullish momentum. Recent news highlights significant institutional interest with BlackRock's IBIT recording $196 million in daily inflows (24/7 Wall Street, 2026-10-04). The stock faces pressure from oscillators but maintains key support levels at $44-$46.
The outlook remains cautious with institutional inflows providing support, but technical weakness and lack of fundamental data create uncertainty. Investment opportunities exist if technical support holds, while risks include market volatility and dependency on broader Bitcoin ETF trends. Investors should monitor institutional flow data and technical breakouts for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →
